Mercury Bio, a biotech company based in Santa Fe, NM, has teamed up with Himed, a producer of bioceramics and biocompatible surface treatments for medical and dental implants. Together, they are working on developing an innovative osteogenic material specifically designed for orthopedic applications. The goal of this collaboration is to create a one-of-a-kind material that can be utilized in bone cements, coatings for implantable devices, and various other applications.
Mercury Bio's groundbreaking technology, known as yEV, involves the use of extracellular vesicles (EVs) that have been engineered to carry specific RNAs and small-molecule drugs. These EVs will be loaded into an organic calcium phosphate-based scaffold created by Himed. This unique combination will not only promote bone healing but also stimulate growth.
Himed is renowned for its expertise in producing bioceramics and developing biocompatible surface treatments for medical and dental implants. In fact, the company recently joined forces with Lithoz, a leading 3D printer manufacturer, to explore new approaches to healing using calcium phosphates.